8 results match your criteria: "Zhengzhou University Children's Hospital[Affiliation]"
Oxid Med Cell Longev
May 2022
Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Doxorubicin (DOX) is an efficient antitumor anthracycline drug, but its cardiotoxicity adversely affects the prognosis of the patients. In this study, we explored whether endogenous gasotransmitter hydrogen sulfide (HS) could protect against DOX-induced cardiomyocyte apoptosis and its mechanisms. The results indicated that DOX significantly downregulated endogenous HS production and endogenous synthetase cystathionine -lyase (CSE) expression and obviously stimulated the apoptosis in H9C2 cells.
View Article and Find Full Text PDFFront Cell Dev Biol
October 2021
Department of Pediatrics, Peking University First Hospital, Beijing, China.
SO, previously known as the product of industrial waste, has recently been proven to be a novel gasotransmitter in the cardiovascular system. It is endogenously produced from the metabolism pathway of sulfur-containing amino acids in mammalians. Endogenous SO acts as an important controller in the regulation of many biological processes including cardiovascular physiological and pathophysiological events.
View Article and Find Full Text PDFFront Pharmacol
April 2021
Department of Anesthesiology, HENAN Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou University Children's Hospital, Zhengzhou, China.
: This study was designed to investigate the effects of three different doses of dexmedetomidine in caudal blocks on postoperative stress and pain after pediatric urethroplasty. A total of 160 children who underwent elective urethroplasty were enrolled in this study. They were randomly divided into four groups: groups D1, D2, and D3, in which the patients were injected respectively with a mixed solution of 1, 1.
View Article and Find Full Text PDFZhonghua Yi Xue Yi Chuan Xue Za Zhi
December 2020
Rehabilitation Center, Zhengzhou University Children's Hospital, Henan Provincial Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, Henan 450053, China.
Objective: To explore the clinical and genetic characteristics of a child featuring developmental delay.
Methods: The child was subjected to whole exome sequencing. Candidate variant was verified by Sanger sequencing.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2019
Department of Hematology and Oncology, The Children's Hospital Affiliated to Zhengzhou University (Children's Hospital of Henan Province, Children's Hospital of Zhengzhou), Zhengzhou 450000, Henan Province, China.
Objective: To analyze and investigate the expression levels of HES1, C-MYC and NF-kB in peripheral blood of patients with T cell acute lymphoblastic leukemia (T-ALL) and their significance.
Methods: Sixty patients with T-ALL and 60 patients with acute myelogenous leukemia (AML) diagnosed in our hospital from June 2012 to March 2015 were enrolled in T-ALL group and AML group, respectively. Another 30 healthy people were enrolled in the control group.
Zhonghua Er Ke Za Zhi
September 2019
Henan Provincial Key Laboratory of Children's Genetics and Metabolic Disease, Children's Hospital Affiliated to Zhengzhou University/Children's Hospital of Henan Province, Zhengzhou 450018, China.
Zhongguo Dang Dai Er Ke Za Zhi
October 2018
Children's Hospital of Zhengzhou University/Children's Hospital of Henan Province/Zhengzhou Children's Hospital/Zhengzhou Children's Critical Medical Key Laboratory, Zhengzhou 450000, China.
Zhongguo Dang Dai Er Ke Za Zhi
August 2018
Department of Emergency and Critical Medicine, Children's Hospital of Zhengzhou University/Children's Hospital of Henan Province/Zhengzhou Children's Hospital/Zhengzhou Children's Key Laboratory of Critical Care Medicine, Zhengzhou 450003, China.
Objective: To observe the effects of L-carnitine treatment on serum levels of brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) and cardiac function in children with heart dysfunction and severe hand-foot-mouth disease (HFMD).
Methods: A total of 120 children with severe HFMD were enrolled and randomly and equally divided into routine treatment group and L-carnitine treatment group. Thirty healthy children served as the control group.